ED
DNOW icon

Exane Derivatives’s DNOW Inc DNOW Stock Holding History

Exane Derivatives’s Portfolio DNOW Stock Details DNOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-174
Closed -$3.46K – 546
2015
Q2 		$3.46K Hold
174
– – ﹤0.01% 401
2015
Q1 		$3.77K Hold
174
– – ﹤0.01% 411
2014
Q4 		$4.48K Buy
+174
New +$4.76K ﹤0.01% 439

Other funds holding DNOW

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AVC
Arlington Value Capital Salt Lake City, Utah $688M AUM 23.52% 1-Year Est. Return
OH
Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Exane Derivatives's DNOW Position: Q3 2015 in Review

Exane Derivatives sold out of DNOW Inc (DNOW) in Q3 2015, closing a stake of 174 shares — an estimated $3.46K sold.

Exane Derivatives first reported a position in DNOW in Q4 2014 and held it in 3 quarters. The position peaked at $4.48K in Q4 2014. 298 funds tracked by Wall St. Rank hold DNOW as of Q3 2015.

  • Exane Derivatives reported no remaining DNOW Inc position as of Q3 2015 after selling out during the quarter.
  • Exane Derivatives sold 174 DNOW Inc shares in Q3 2015, an estimated $3.46K.
  • Exane Derivatives first reported a position in DNOW Inc in Q4 2014 and held it in 3 quarters.
  • Exane Derivatives's DNOW Inc position peaked at $4.48K in Q4 2014.
  • 298 funds tracked by Wall St. Rank held DNOW Inc as of Q3 2015.

Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.